` GBT (Guerbet SA) vs DAX Index Comparison - Alpha Spread

GBT
vs
D
DAX Index

Over the past 12 months, GBT has underperformed DAX Index, delivering a return of -44% compared to the DAX Index's +20% growth.

Stocks Performance
GBT vs DAX Index

Loading
GBT
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
GBT vs DAX Index

Loading
GBT
DAX Index
Difference
www.alphaspread.com

Performance By Year
GBT vs DAX Index

Loading
GBT
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Guerbet SA vs Peers

DAX Index
GBT
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Guerbet SA
Glance View

Market Cap
174.9m EUR
Industry
Health Care

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company is headquartered in Villepinte, Ile-De-France and currently employs 2,730 full-time employees. The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

GBT Intrinsic Value
49.19 EUR
Undervaluation 72%
Intrinsic Value
Price
Back to Top